News Details

( 13 Sep 2022)
AstraZeneca Pharma I - Increase In Volume

This has reference to your email dated September 13, 2022 bearing reference no. L/SURV/ONL/PV/SR/ 2022-2023 / 191 on the captioned subject.\r\n\r\nWe wish to inform you that we have no information/announcement including pending announcement which in the Company's opinion may have a bearing on the price/volume behaviour in the scrip. \r\n\r\nWe thank you for drawing our attention and assure you of Company's continued adherence to its obligation under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.